Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Accenture
Fuji
US Army
Federal Trade Commission
Fish and Richardson
Daiichi Sankyo
Deloitte
McKesson

Generated: September 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021546

« Back to Dashboard

NDA 021546 describes REBETOL, which is a drug marketed by Merck Sharp Dohme and Schering and is included in two NDAs. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the REBETOL profile page.

The generic ingredient in REBETOL is ribavirin. There are fifteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ribavirin profile page.
Summary for 021546
Tradename:REBETOL
Applicant:Schering
Ingredient:ribavirin
Patents:3
Formulation / Manufacturing:see details
Pharmacology for NDA: 021546
Ingredient-typeNucleoside Analog
Medical Subject Heading (MeSH) Categories for 021546
Suppliers and Packaging for NDA: 021546
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
REBETOL ribavirin SOLUTION;ORAL 021546 NDA Merck Sharp & Dohme Corp. 0085-1318 0085-1318-01 1 BOTTLE in 1 CARTON (0085-1318-01) > 100 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength40MG/ML
Approval Date:Jul 29, 2003TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Mar 21, 2018Product Flag?Substance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Mar 21, 2018Product Flag?Substance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Oct 5, 2023Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 021546

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 ➤ Sign Up ➤ Sign Up
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 ➤ Sign Up ➤ Sign Up
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 ➤ Sign Up ➤ Sign Up
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 ➤ Sign Up ➤ Sign Up
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 ➤ Sign Up ➤ Sign Up
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 ➤ Sign Up ➤ Sign Up
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Fish and Richardson
Harvard Business School
Queensland Health
Dow
AstraZeneca
Daiichi Sankyo
Merck
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.